FR2413090A1 - Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine - Google Patents

Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine

Info

Publication number
FR2413090A1
FR2413090A1 FR7800083A FR7800083A FR2413090A1 FR 2413090 A1 FR2413090 A1 FR 2413090A1 FR 7800083 A FR7800083 A FR 7800083A FR 7800083 A FR7800083 A FR 7800083A FR 2413090 A1 FR2413090 A1 FR 2413090A1
Authority
FR
France
Prior art keywords
erythromycin
against infections
pharmaceutical preparation
preparation based
ethylsuccinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7800083A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2413090A1 publication Critical patent/FR2413090A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Abstract

CETTE PREPARATION EST CONSTITUEE, SELON L'INVENTION, DE GRANULES CONTENANT 100 PARTIES D'ETHYLSUCCINATE D'ERYTHROMYCINE, 3 A 100 PARTIES D'UNE GOMME CONVENANT EN PHARMACIE ET 20 A 4000 PARTIES D'UN SUCRE CONVENANT EN PHYSIOLOGIE. LA PREPARATION DE L'INVENTION, QUE L'ON PEUT ADMINISTRER SOUS FORME D'UNE SUSPENSION OU DE COMPRIMES A MACHER, EST UTILE NOTAMMENT POUR LUTTER CONTRE LES INFECTIONS SENSIBLES A L'ERYTHROMYCINE DE L'HOMME ET DES ANIMAUX A SANG CHAUD NON A JEUN.
FR7800083A 1975-07-18 1978-01-03 Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine Withdrawn FR2413090A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59705775A 1975-07-18 1975-07-18

Publications (1)

Publication Number Publication Date
FR2413090A1 true FR2413090A1 (fr) 1979-07-27

Family

ID=24389898

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7800083A Withdrawn FR2413090A1 (fr) 1975-07-18 1978-01-03 Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine

Country Status (6)

Country Link
US (1) US4076804A (fr)
JP (1) JPS5486605A (fr)
AU (1) AU3172277A (fr)
BE (1) BE862642A (fr)
DE (1) DE2758942A1 (fr)
FR (1) FR2413090A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0349514A1 (fr) * 1988-07-01 1990-01-03 "PHARLYSE", Société Anonyme Composition pharmaceutique d'érythromycine à libération prolongée, sa préparation et son utilisation

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US5118799A (en) * 1987-05-12 1992-06-02 Pharmacin Corporation Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate
IN192748B (fr) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
WO2003017981A1 (fr) 2001-08-29 2003-03-06 Ranbaxy Laboratories Limited Formulation a liberation controlee de clarithromycine ou de tinidazol
HUP0500791A2 (en) * 2001-08-29 2006-09-28 Ranbaxy Lab Ltd Controlled release formulation of clarithromycin or tinidazol
CN109846839B (zh) * 2019-01-31 2021-03-16 河北君临药业有限公司 一种琥乙红霉素颗粒及其制备方法

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB844772A (en) * 1956-04-19 1960-08-17 Pfizer & Co C Granular pharmaceutical compositions and process for preparing same
FR1258497A (fr) * 1959-04-30 1961-04-14 Wisconsin Alumni Res Found Procédé de granulation
US3084104A (en) * 1961-06-28 1963-04-02 Richardson Merrell Inc Process of preparing granulation of medicinal agents
FR2116M (fr) * 1962-02-05 1963-11-04 Vitamix Pharmaceuticals Compositions thérapeutiques a action prolongée pour l'administration orale de l'oxy-tétracycline.
FR1360432A (fr) * 1963-04-24 1964-05-08 Dairy Mour Procédé pour agglomérer des particules difficiles à agglomérer et produit obtenu
GB974917A (en) * 1961-10-31 1964-11-11 Warner Lambert Pharmaceutical Preparation of a modified mannitol product
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
FR1503582A (fr) * 1966-07-18 1967-12-01 Sedaph Soc D Applic Pharma Sa Procédé de préparation d'une nouvelle forme solide de médicament
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
FR2042385A1 (fr) * 1969-04-29 1971-02-12 Sucrest Corp
FR2042384A1 (fr) * 1969-04-29 1971-02-12 Sucrest Corp
NL6913334A (en) * 1969-09-01 1971-03-03 Producing readily soluble and dispersible - granulates
FR2140217A1 (fr) * 1971-06-03 1973-01-12 Mundipharma Ag
DE2217652A1 (de) * 1972-04-12 1973-10-18 Paolo Dr Sorbini Lyophilisierte arzneimittelprodukte und verfahren zu ihrer herstellung
FR2221179A1 (fr) * 1973-03-16 1974-10-11 Meiji Seika Co
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
FR2336919A1 (fr) * 1976-01-02 1977-07-29 Beecham Group Ltd Composition pharmaceutique pour l'administration orale sous forme de granules contenant une penicilline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878192A (en) * 1972-06-05 1975-04-15 Blasina Lab Chim Farm Sweet and palatable water soluble derivatives of erythromycin
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB844772A (en) * 1956-04-19 1960-08-17 Pfizer & Co C Granular pharmaceutical compositions and process for preparing same
FR1258497A (fr) * 1959-04-30 1961-04-14 Wisconsin Alumni Res Found Procédé de granulation
US3084104A (en) * 1961-06-28 1963-04-02 Richardson Merrell Inc Process of preparing granulation of medicinal agents
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
GB974917A (en) * 1961-10-31 1964-11-11 Warner Lambert Pharmaceutical Preparation of a modified mannitol product
FR2116M (fr) * 1962-02-05 1963-11-04 Vitamix Pharmaceuticals Compositions thérapeutiques a action prolongée pour l'administration orale de l'oxy-tétracycline.
FR1360432A (fr) * 1963-04-24 1964-05-08 Dairy Mour Procédé pour agglomérer des particules difficiles à agglomérer et produit obtenu
FR1503582A (fr) * 1966-07-18 1967-12-01 Sedaph Soc D Applic Pharma Sa Procédé de préparation d'une nouvelle forme solide de médicament
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
FR2042385A1 (fr) * 1969-04-29 1971-02-12 Sucrest Corp
FR2042384A1 (fr) * 1969-04-29 1971-02-12 Sucrest Corp
NL6913334A (en) * 1969-09-01 1971-03-03 Producing readily soluble and dispersible - granulates
FR2140217A1 (fr) * 1971-06-03 1973-01-12 Mundipharma Ag
DE2217652A1 (de) * 1972-04-12 1973-10-18 Paolo Dr Sorbini Lyophilisierte arzneimittelprodukte und verfahren zu ihrer herstellung
FR2221179A1 (fr) * 1973-03-16 1974-10-11 Meiji Seika Co
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
FR2336919A1 (fr) * 1976-01-02 1977-07-29 Beecham Group Ltd Composition pharmaceutique pour l'administration orale sous forme de granules contenant une penicilline

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0349514A1 (fr) * 1988-07-01 1990-01-03 "PHARLYSE", Société Anonyme Composition pharmaceutique d'érythromycine à libération prolongée, sa préparation et son utilisation
BE1002079A4 (fr) * 1988-07-01 1990-06-19 S M B Lab Composition pharmaceutique d'erythromycine a liberation prolongee, sa preparation et son utilisation.

Also Published As

Publication number Publication date
BE862642A (fr) 1978-07-04
JPS5486605A (en) 1979-07-10
AU3172277A (en) 1979-06-28
DE2758942A1 (de) 1979-07-05
US4076804A (en) 1978-02-28

Similar Documents

Publication Publication Date Title
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2290912A1 (fr) Formulations pharmaceutiques contenant de la l-dopa ou ses derives
ES2095043T3 (es) Composicion para preparados orales.
FR2334359A1 (fr) Derives de l'isoquinoleine, leur preparation et medicaments contenant ces substances
FR2293928A1 (fr) Nouveaux derives d'acide 3-amino-indazolecarboxylique, leur procede de preparation et medicament les contenant
FR2413090A1 (fr) Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine
KR930005619A (ko) 위장 질환 치료용 약제
NO180473C (no) Fremgangsmåte for fremstilling av et enteralt, farmasöytisk fôrpreparat for behandling av ektoparasittiske fiskesykdommer
BE885605A (fr) Derives d'acide benzo(ij)quinolizine-carboxylique-2, utiles notamment comme medicaments antimicrobiens, procede de leur preparation et compositions therapeutiques et formes pharmaceutiques les contenant
US3144387A (en) Anti-inflammatory compositions
BG101709A (en) New applications of lysozyme dimer
IL82523A0 (en) Microbicidal compositions,their manufacture and drugs containing them
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
FR2390424A1 (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur application
CA2078869A1 (fr) Compositions pharmaceutiques contenant de l'ipriflavone, leur procede de preparation et leur emploi therapeutique relatif
FR2640269B1 (fr) Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
FR2388562A1 (fr) Medicament contenant de la 5'-amino-5'-desoxythymidine ou un sel de cette substance
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
HUP0104716A2 (hu) Szarkoszisztiszre, neospórára és toxoplazmára visszavezethető betegségek kezelésére alkalmas triazinonszármazékok és ezeket tartalmazó gyógyszerkészítmények
EP0302836B1 (fr) Compositions pharmaceutiques pour usage topique contenant de la miocamycine
BE753172A (fr) Derives d'acide aryloxy-acetiques et arylthio-acetiques et medicaments contenant de tels composes
SE8705136D0 (sv) Oral doseringsenhet for lekemedel och dess anvendning och framstellning
JPS60120811A (ja) 軟質ゼラチンカプセル

Legal Events

Date Code Title Description
ST Notification of lapse